Effect of epoetin alpha therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy

European Journal of Cancer Care
G IconomouH P Kalofonos

Abstract

The primary aim of this study was to assess whether epoetin alpha (Ea) would improve cognitive performance in a group of anaemic cancer patients receiving chemotherapy. The secondary aim was to confirm the positive impact of Ea on haematological parameters, and quality of life (QOL). Fifty patients with solid tumours and haemoglobin (Hb) <11.0 g/dL received Ea 40,000 units once weekly for 12 weeks and were administered the Mini-Mental State Examination and the European Organization for Research and Treatment of Cancer (QLQ-C30) questionnaire prior to Ea therapy and at study completion. No clinically significant alterations were observed on cognitive function during Ea treatment. Changes in cognitive function were unrelated to Hb change and there were no significant differences in cognitive performance between Ea responders and non-responders. The analyses revealed clinically significant improvements in Hb levels, physical and role function, and clinically meaningful reductions in fatigue. Hb changes were significantly associated with the magnitude of improvement in QOL parameters. The lack of a clinical benefit in cognition observed in this study during Ea treatment may redirect the focus of research from enhancing to maintaini...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jan 1, 1991·Kidney International·J T MarshA R Nissenson
Jun 3, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J L PickettA R Nissenson
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·M L BrinesA Cerami
Feb 7, 2002·European Journal of Cancer Care·S E LibrettoR Thomas
Feb 6, 2003·Journal of the National Cancer Institute·Kelly-Anne Phillips, Jürg Bernhard
Aug 13, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christina A Meyers, Jeffrey S Wefel
Nov 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nadine TchenIan F Tannock
Dec 23, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M PoppelreuterH H Bartsch
Feb 3, 2004·The Oncologist·David H Henry
Mar 18, 2004·Cancer Nursing·Regina S Cunningham
Jun 30, 2004·Journal of Pain and Symptom Management·Paul B JacobsenEdward Grendys
Aug 25, 2004·Cancer Treatment Reviews·Erminia FerrarioEmilio Bajetta
Sep 30, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C BokemeyerP Soubeyran
Nov 24, 2004·Metabolic Brain Disease·Hannelore EhrenreichAnna-Leena Sirén
Mar 29, 2005·Best Practice & Research. Clinical Haematology·Jayesh Desai, George D Demetri
Oct 28, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A MancusoF De Marinis
Apr 6, 2006·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·M Milano, R Collomp
Apr 21, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·U WeddingL Pientka
May 18, 2006·Journal of the National Cancer Institute·Julia BohliusAndreas Engert

❮ Previous
Next ❯

Citations

Nov 28, 2014·Clinical Journal of Oncology Nursing·Diane Von AhDeborah H Allen
Nov 25, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Samantha J MayoKatherine B Peters

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.